Outcomes and Cosmesis With Whole Breast Irradiation and Boost

Recruiting N/A Interventional Study
Early-stage Breast Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
University of Wisconsin, Madison · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Ability to understand and the willingness to sign a written informed consent document * Histologically confirmed early stage (stage T1-T2) invasive carcinoma of the breast or DCIS * Breast conserving surgery with negative margins and negative nodes (surgical axillary staging n…
Contacts

Cancer Connect

800-622-8922

clinicaltrials@cancer.wisc.edu

CONTACT